In this issue:
Epidemiology
Supplementation, HRT, colorectal cancer
Patterns of care
Factors affecting access to cancer care
Anal cancer
Cisplatin-based therapy for anal canal carcinoma?
Advanced disease
Bevacizumab + oxaliplatin-based chemo in MCC?
Irinotecan-containing chemotherapy in CRC for all?
Preoperative chemotherapy before liver resection?
First-line XELOX vs FOLFOX-4 in MCRC
First-line cetuximab in MCRC
Pharmacogenetic profiling for salvage therapy
Prognosis
Nomogram predicts survival after liver resection?
Prognostic model for survival in mCRC
Please login below to download this issue (PDF)